FGF21 and type 2 diabetes mellitus: Circulating FGF21 levels have been found to be elevated in patients and experimental animals with various metabolic conditions, such as obesity (Dushay et al., 2010), non-alcoholic fatty liver disease (Kim et al., 2015), and type 2 diabetes (Barb et al., 2019).